Delivery Order SPE2DB22D1017-SPE2DB25FG9CP
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $3,478.24 to AmerisourceBergen Drug Corp for the supply of Trulicity 1.5 mg/0.5 mL pens (0.5 mL units), a diabetes medication. This firm fixed-price, non-set-aside contract was awarded on July 30, 2025, with a completion date of July 31, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a single transaction within the company's broader...
- The Defense Logistics Agency awarded a delivery order valued at $3,003.00 to AmerisourceBergen Drug Corp for the supply of Trulicity 1.5 mg/0.5 mL pens (0.5 mL units), a diabetes medication. This firm fixed price, competitively awarded delivery order has an ultimate completion date of July 29, 2025, and will be performed at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. The contract carries no set-aside designation, reflecting the vendor's demonstrated capability to...
- The Defense Logistics Agency awarded a $3,073.44 delivery order to AmerisourceBergen Drug Corp for Trulicity 1.5 mg/0.5 mL pens on August 4, 2025, with completion scheduled for August 5, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and represents a single delivery order under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical. The product will be delivered to AmerisourceBergen's facility in Conshohocken,...
- The Defense Logistics Agency awarded a $2,015.65 delivery order to AmerisourceBergen Drug Corp for Trulicity 4.5 mg/0.5 ml pen (0.5 ml), a diabetes medication, on August 8, 2025, with completion expected by August 11, 2025. This is a firm fixed price, non-set-aside contract with performance at AmerisourceBergen's Conshohocken, Pennsylvania facility. The delivery order was competitively awarded and represents a child contract under AmerisourceBergen's larger relationship with the federal...
- The Defense Logistics Agency awarded a $1,351.35 delivery order to AmerisourceBergen Drug Corp for Trulicity 3 mg/0.5 mL pens on August 1, 2025, with completion targeted for August 4, 2025. This firm fixed price, competitively awarded contract involves the supply of the diabetes medication from AmerisourceBergen's Conshohocken, Pennsylvania facility. The award carries no set-aside designation and represents a child order under AmerisourceBergen's larger contract vehicle with the Defense...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Trulicity 1.5 mg/0.5 mL pen (0.5 mL) under a firm fixed-price contract. The order, valued at $3,840.29, was competitively awarded without set-aside designation and is scheduled for completion by August 8, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its Corporate Office location. This delivery order is issued under AmerisourceBergen...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,970.28 to AmerisourceBergen Drug Corp for the supply of Trulicity 0.75 mg/0.5 mL pens (0.5 mL units), a diabetes medication. The contract was awarded on July 25, 2025, with an ultimate completion date of July 28, 2025, and carries firm fixed pricing with no set-aside designation. The award represents a competitively awarded delivery order under AmerisourceBergen's existing contract vehicle with DLA, reflecting the company's...
- The Defense Logistics Agency awarded a delivery order valued at $2,036.86 to AmerisourceBergen Drug Corp for the supply of Trulicity 0.75 mg/0.5 ml pen (0.5 ml), a diabetes medication. The contract, awarded on July 30, 2025, carries a firm fixed price structure with an ultimate completion date of July 31, 2025, and will be performed at the vendor's Conshohocken, Pennsylvania location. This delivery order was competitively awarded with no set-aside designation, reflecting AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $1,042.42 to AmerisourceBergen Drug Corp for Trulicity 1.5 mg/0.5 ml pens on July 30, 2025, with an ultimate completion date of July 31, 2025. This firm fixed-price delivery order, which was competitively awarded without set-aside designation, is performed at the contractor's location in Conshohocken, Pennsylvania. The award represents a single transaction under AmerisourceBergen's larger contract vehicle with DLA for pharmaceutical...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,603.60 to AmerisourceBergen Drug Corp for the supply of Trulicity 3 mg/0.5 mL pens (0.5 mL units), a diabetes medication. This contract was competitively awarded without set-aside designation under a firm fixed-price delivery order structure, with an ultimate completion date of August 11, 2025. The pharmaceutical products will be delivered to the place of performance in Conshohocken, Pennsylvania, which serves as...
- SPE2DB22D1017Indefinite Delivery Contract
- SPE2DB22D1017-SPE2DB25FG9CPDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $3,003.00 to AmerisourceBergen Drug Corp for Trulicity 1.5 mg/0.5 mL pen (0.5 mL), a diabetes medication. The contract was awarded on August 7, 2025, with an ultimate completion date of August 8, 2025, and represents a firm fixed price, non-set-aside competitive award. Performance will be executed at the vendor's corporate office location in Conshohocken, Pennsylvania. This delivery order operates under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999.99 million through December 2026. This prime contract vehicle supports comprehensive global pharmaceutical supply to military healthcare programs and enables the company to fulfill medical supply needs across multiple therapeutic domains for the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems. AmerisourceBergen Drug Corp's federal contracting history demonstrates consistent capability to meet DLA requirements through competitive procurement, with delivery orders ranging significantly in value and encompassing a diverse pharmaceutical portfolio including specialty medications, brand-name and generic drugs, and medical supplies.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.0k | 8/7/25 |